These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33068291)

  • 21. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
    Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
    Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution.
    Di Gravio EJ; Lang P; Kim HAJ; Chinnery T; Mundi N; MacNeil SD; Mendez A; Yoo J; Fung K; Mymryk JS; Barrett JW; Read N; Venkatesan V; Kuruvilla S; Mendez LC; Winquist E; Mitchell S; Mattonen SA; Nichols AC; Palma DA
    Radiat Oncol; 2020 Nov; 15(1):261. PubMed ID: 33168055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Zumsteg ZS; Lok BH; Ho AS; Drill E; Zhang Z; Riaz N; Shiao SL; Ma J; McBride SM; Tsai CJ; Baxi SS; Sherman EJ; Lee NY
    Cancer; 2017 Apr; 123(8):1345-1353. PubMed ID: 27984656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary surgery versus chemoradiotherapy for advanced oropharyngeal cancers: a longitudinal population study.
    O'Connell D; Seikaly H; Murphy R; Fung C; Cooper T; Knox A; Scrimger R; Harris JR
    J Otolaryngol Head Neck Surg; 2013; 42(1):31. PubMed ID: 23663568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
    Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
    Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
    Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
    Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
    Kalavrezos N; Cotrufo S; Govender R; Rogers P; Pirgousis P; Balasundram S; Lalabekyan B; Liew C
    Head Neck; 2014 Jan; 36(1):47-54. PubMed ID: 23559533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.
    Lop J; García J; López M; Taberna M; Mena M; Alemany L; Quer M; León X
    Head Neck; 2019 May; 41(5):1328-1334. PubMed ID: 30549389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multistep and Multidisciplinary Management for Post-irradiated Carotid Blowout Syndrome in a Young Patient With Oropharyngeal Carcinoma: A Case Report.
    Sallustro M; Abualhin M; Faggioli G; Pilato A; Dall'Olio D; Simonetti L; Astarita F; Amorosa L; Gargiulo M
    Ann Vasc Surg; 2020 Aug; 67():565.e1-565.e5. PubMed ID: 32209410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional outcomes after treatment of advanced oropharyngeal carcinoma with radiation or chemoradiation.
    Myers C; Kerr P; Cooke A; Bammeke F; Butler J; Lambert P
    J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):108-18. PubMed ID: 22569011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment.
    Spector ME; Chinn SB; Bellile E; Gallagher KK; Kang SY; Moyer JS; Prince ME; Wolf GT; Bradford CR; McHugh JB; Carey TE; Worden FP; Eisbruch A; Ibrahim M; Chepeha DB
    JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):313-8. PubMed ID: 26892642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.
    Hinther A; Samson N; Lau H; Quon H; Banerjee R; Lysack JT; Grendarova P; Matthews TW; Randall DR
    Laryngoscope; 2020 Mar; 130(3):597-602. PubMed ID: 31260128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depth of invasion applied to oropharynx does not improve prognosis discrimination according to AJCC stage groups for oral cancer.
    Matos LL; Pinheiro RA; Kowalski LP
    Oral Oncol; 2020 Dec; 111():104890. PubMed ID: 32654870
    [No Abstract]   [Full Text] [Related]  

  • 35. Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma.
    Jouhi L; Atula T; Saarilahti K; Hagström J; Haglund C; Mohamed H; Mäkitie A; Keski-Säntti H
    Head Neck; 2017 Jul; 39(7):1412-1420. PubMed ID: 28464452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Kraaijenga SA; Hamming-Vrieze O; Verheijen S; Lamers E; van der Molen L; Hilgers FJ; van den Brekel MW; Heemsbergen WD
    Head Neck; 2019 May; 41(5):1387-1394. PubMed ID: 30652390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
    Bar-Ad V; Wang ZX; Leiby B; Tuluc M
    J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.
    Roskies M; Kay-Rivest E; Mascarella MA; Sultanem K; Mlynarek A; Hier M
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):50. PubMed ID: 27724969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.
    Clavel S; Nguyen DH; Fortin B; Després P; Khaouam N; Donath D; Soulières D; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):582-9. PubMed ID: 21277695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.